92 related articles for article (PubMed ID: 16390316)
1. Biological implications of filamin A-bound PEBP2beta/CBFbeta retention in the cytoplasm.
Watanabe T; Yoshida N; Satake M
Crit Rev Eukaryot Gene Expr; 2005; 15(3):197-206. PubMed ID: 16390316
[TBL] [Abstract][Full Text] [Related]
2. Filamin A-bound PEBP2beta/CBFbeta is retained in the cytoplasm and prevented from functioning as a partner of the Runx1 transcription factor.
Yoshida N; Ogata T; Tanabe K; Li S; Nakazato M; Kohu K; Takafuta T; Shapiro S; Ohta Y; Satake M; Watanabe T
Mol Cell Biol; 2005 Feb; 25(3):1003-12. PubMed ID: 15657428
[TBL] [Abstract][Full Text] [Related]
3. The protooncogene product, PEBP2beta/CBFbeta, is mainly located in the cytoplasm and has an affinity with cytoskeletal structures.
Tanaka Y; Watanabe T; Chiba N; Niki M; Kuroiwa Y; Nishihira T; Satomi S; Ito Y; Satake M
Oncogene; 1997 Aug; 15(6):677-83. PubMed ID: 9264408
[TBL] [Abstract][Full Text] [Related]
4. Differentiation dependent expression and distinct subcellular localization of the protooncogene product, PEBP2beta/CBFbeta, in muscle development.
Chiba N; Watanabe T; Nomura S; Tanaka Y; Minowa M; Niki M; Kanamaru R; Satake M
Oncogene; 1997 May; 14(21):2543-52. PubMed ID: 9191054
[TBL] [Abstract][Full Text] [Related]
5. Genetic evidence of PEBP2beta-independent activation of Runx1 in the murine embryo.
Yokomizo T; Yanagida M; Huang G; Osato M; Honda C; Ema M; Takahashi S; Yamamoto M; Ito Y
Int J Hematol; 2008 Sep; 88(2):134-138. PubMed ID: 18594778
[TBL] [Abstract][Full Text] [Related]
6. Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation.
Huang G; Shigesada K; Ito K; Wee HJ; Yokomizo T; Ito Y
EMBO J; 2001 Feb; 20(4):723-33. PubMed ID: 11179217
[TBL] [Abstract][Full Text] [Related]
7. The PEBP2beta/CBF beta-SMMHC chimeric protein is localized both in the cell membrane and nuclear subfractions of leukemic cells carrying chromosomal inversion 16.
Kanto S; Chiba N; Tanaka Y; Fujita S; Endo M; Kamada N; Yoshikawa K; Fukuzaki A; Orikasa S; Watanabe T; Satake M
Leukemia; 2000 Jul; 14(7):1253-9. PubMed ID: 10914550
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for a dominant inactivation of RUNX1/AML1 by the leukemogenic inversion 16 chimera.
Huang G; Shigesada K; Wee HJ; Liu PP; Osato M; Ito Y
Blood; 2004 Apr; 103(8):3200-7. PubMed ID: 15070703
[TBL] [Abstract][Full Text] [Related]
9. Filamin A negatively regulates the transcriptional activity of p73alpha in the cytoplasm.
Kim EJ; Park JS; Um SJ
Biochem Biophys Res Commun; 2007 Nov; 362(4):1101-6. PubMed ID: 17825253
[TBL] [Abstract][Full Text] [Related]
10. The chimeric protein, PEBP2 beta/CBF beta-SMMHC, disorganizes cytoplasmic stress fibers and inhibits transcriptional activation.
Tanaka Y; Fujii M; Hayashi K; Chiba N; Akaishi T; Shineha R; Nishihira T; Satomi S; Ito Y; Watanabe T; Satake M
Oncogene; 1998 Aug; 17(6):699-708. PubMed ID: 9715271
[TBL] [Abstract][Full Text] [Related]
11. PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis.
Wee HJ; Voon DC; Bae SC; Ito Y
Blood; 2008 Nov; 112(9):3777-87. PubMed ID: 18695000
[TBL] [Abstract][Full Text] [Related]
12. Crlz1 activates transcription by mobilizing cytoplasmic CBFbeta into the nucleus.
Park SK; Lim JH; Kang CJ
Biochim Biophys Acta; 2009; 1789(11-12):702-8. PubMed ID: 19735751
[TBL] [Abstract][Full Text] [Related]
13. Structure and Biophysics of CBFβ/RUNX and Its Translocation Products.
Tahirov TH; Bushweller J
Adv Exp Med Biol; 2017; 962():21-31. PubMed ID: 28299648
[TBL] [Abstract][Full Text] [Related]
14. Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases.
Bedolla RG; Wang Y; Asuncion A; Chamie K; Siddiqui S; Mudryj MM; Prihoda TJ; Siddiqui J; Chinnaiyan AM; Mehra R; de Vere White RW; Ghosh PM
Clin Cancer Res; 2009 Feb; 15(3):788-96. PubMed ID: 19188148
[TBL] [Abstract][Full Text] [Related]
15. GPIbα regulates platelet size by controlling the subcellular localization of filamin.
Kanaji T; Ware J; Okamura T; Newman PJ
Blood; 2012 Mar; 119(12):2906-13. PubMed ID: 22174152
[TBL] [Abstract][Full Text] [Related]
16. Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers.
Illendula A; Gilmour J; Grembecka J; Tirumala VSS; Boulton A; Kuntimaddi A; Schmidt C; Wang L; Pulikkan JA; Zong H; Parlak M; Kuscu C; Pickin A; Zhou Y; Gao Y; Mishra L; Adli M; Castilla LH; Rajewski RA; Janes KA; Guzman ML; Bonifer C; Bushweller JH
EBioMedicine; 2016 Jun; 8():117-131. PubMed ID: 27428424
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of core binding factorβ alters sphingolipid metabolism.
Greer AH; Yong T; Fennell K; Moustafa YW; Fowler M; Galiano F; Ng SW; Berkowitz RS; Cardelli J; Meyers S; Davis JN
J Cell Physiol; 2013 Dec; 228(12):2350-64. PubMed ID: 23813439
[TBL] [Abstract][Full Text] [Related]
18. Core binding factor β (CBFβ) is retained in the midbody during cytokinesis.
Lopez-Camacho C; van Wijnen AJ; Lian JB; Stein JL; Stein GS
J Cell Physiol; 2014 Oct; 229(10):1466-74. PubMed ID: 24648201
[TBL] [Abstract][Full Text] [Related]
19. A novel partner for Dictyostelium filamin is an alpha-helical developmentally regulated protein.
Knuth M; Khaire N; Kuspa A; Lu SJ; Schleicher M; Noegel AA
J Cell Sci; 2004 Oct; 117(Pt 21):5013-22. PubMed ID: 15383615
[TBL] [Abstract][Full Text] [Related]
20. Localization and enhanced current density of the Kv4.2 potassium channel by interaction with the actin-binding protein filamin.
Petrecca K; Miller DM; Shrier A
J Neurosci; 2000 Dec; 20(23):8736-44. PubMed ID: 11102480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
